Table 3 |
||
|
Recommended oral treatment for severe falciparum malaria after initial parenteral therapy for at least 24 hours when clinical improvement is evident and the patient can tolerate oral medication |
||
|
Drug |
Dose |
Comments |
|
|
||
|
Artemether/lumefantrin |
80 mg arthemeter/480 mg lumefantrin once daily for 3 days |
Well tolerated, faster parasite clearance, but longer fever resolution time |
|
Atovaquone/proguanil |
1000 mg atovaquone/400 mg proguanil at 0, 8, 24, 36, 48 and 60 hours |
Well tolerated, more effective than mefloquine in treatment of multidrug-resistant falciparum malaria |
|
Mefloquine |
15 mg/kg (750 mg) base at 0 hours, followed by10 mg/kg (500 mg) base at 6–8 hours, and (if >60 kg) followed by 5 mg/kg (250 mg) at 16 hours |
Contraindicated in persons with seizure or psychiatric disorders, or with cardiac conduction abnormalities |
|
Quinine (sulfate salt) |
10 mg salt/kg (600–650 mg) every 8 hours to complete7 days of treatment (total duration) |
Side effects include cinchonism and pruritus |
|
|
||
|
Trampuz et al. Critical Care 2003 7:315 doi:10.1186/cc2183 |
||